Neuropsychiatric Risks Linked to COVID-19 Revealed

Neuropsychiatric Risks Linked to COVID-19 Revealed

Publication date: Aug 01, 2025

Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis. Leveraging a difference-in-differences analytic approach, renowned for its strength in causal inference from observational data, researchers meticulously compared the incidence of neuropsychiatric disorders in infected individuals versus matched controls. It calls attention to the silent yet serious consequences of the virus that extend well beyond acute respiratory illness, manifesting as a spectrum of mental and neurological health challenges. The data highlighted notable surges in cerebrovascular events such as ischemic strokes and transient ischemic attacks, potentially linked to the prothrombotic state induced by SARS-CoV-2 infection. By integrating data from such a broad population base, the investigators ensured the inclusivity of various demographics, spanning age groups, genders, ethnic backgrounds, and comorbidities. Among these, anxiety disorders and mood disturbances surfaced prominently, pointing to the profound psychological burden exerted by the virus. Older adults, as anticipated, exhibited heightened vulnerability, with more severe infections correlating with an augmented risk.

Concepts Keywords
Base Conditions
Covidneuropsychiatric Cov
Psychotic Covid
Viral Disorders
Infection
Investigation
Neurological
Neuropsychiatric
Pandemic
Post
Psychiatric
Risk
Risks
Sars
Width

Semantics

Type Source Name
disease IDO role
disease MESH psychological distress
disease MESH anxiety disorders
disease MESH cognitive impairments
disease MESH brain fog
disease MESH psychotic disorders
disease MESH neurological manifestations
disease MESH ischemic strokes
disease MESH transient ischemic attacks
disease MESH peripheral neuropathies
disease MESH infection
disease MESH asymptomatic infections
disease MESH inflammation
disease MESH psychiatric disorders
disease MESH Long Covid
pathway REACTOME SARS-CoV-2 Infection
disease MESH sequelae
disease MESH COVID-19

Original Article

(Visited 4 times, 1 visits today)